Literature DB >> 35997838

Prediction of tumor budding in patients with rectal adenocarcinoma using b-value threshold map.

Fangying Chen1, Shaoting Zhang1, Xiaolu Ma1, Yukun Chen1, Zhen Wang1, Yan Zhu2, Chenguang Bai2, Caixia Fu3, Robert Grimm4, Chengwei Shao1, Jianping Lu1, Fu Shen5, Luguang Chen6.   

Abstract

OBJECTIVE: To investigate the feasibility of b-value threshold (bThreshold) map in preoperative evaluation of tumor budding (TB) in patients with locally advanced rectal cancer (LARC).
METHODS: Patients with LARC were enrolled and underwent diffusion-weighted imaging (DWI). Contrast-to-noise ratio (CNR) between the lesions and normal tissues was assessed using DWI and bThreshold maps. TB was counted and scored using hematoxylin and eosin staining. Reproducibility for the apparent diffusion coefficient (ADC), bThreshold values, and region-of-interest (ROI) sizes were compared. Differences in ADC and bThreshold values with low-intermediate and high TB grades and the correlations between mean ADC and bThreshold values with TB categories were analyzed. Diagnostic performance of ADC and bThreshold values was assessed using area under the curve (AUC) and decision curve analysis.
RESULTS: Fifty-one patients were evaluated. The CNR on bThreshold maps was significantly higher than that on DW images (9.807 ± 4.811 vs 7.779 ± 3.508, p = 0.005). Reproducibility was excellent for the ADC (ICC 0.933; CV 8.807%), bThreshold values (ICC 0.958; CV 7.399%), and ROI sizes (ICC 0.934; CV 8.425%). Significant negative correlations were observed between mean ADC values and TB grades and positive correlations were observed between mean bThreshold values and TB grades (p < 0.05). bThreshold maps showed better diagnostic performance than ADC maps (AUC, 0.914 vs 0.726; p = 0.048).
CONCLUSIONS: In LARC patients, bThreshold values could distinguish different TB grades better than ADC values, and bThreshold maps may be a preoperative, non-invasive approach to evaluate TB grades. KEY POINTS: • Compared with diffusion-weighted images, bThreshold maps improved visualization and detection of rectal tumors. • Agreement and diagnostic performance of bThreshold values are superior to apparent diffusion coefficient in assessing tumor budding grades in patients with locally advanced rectal cancer. • bThreshold maps could be used to evaluate tumor budding grades non-invasively before operation.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Clinical pathology; Diffusion magnetic resonance imaging; Rectal cancer

Year:  2022        PMID: 35997838     DOI: 10.1007/s00330-022-09087-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  39 in total

1.  Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer.

Authors:  Iris D Nagtegaal; Marleen J E M Gosens; Corrie A M Marijnen; Harm J Rutten; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  J Clin Oncol       Date:  2007-05-01       Impact factor: 44.544

2.  The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III.

Authors:  S Merkel; U Mansmann; T Papadopoulos; C Wittekind; W Hohenberger; P Hermanek
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

3.  Colorectal cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ann Goding Sauer; Stacey A Fedewa; Lynn F Butterly; Joseph C Anderson; Andrea Cercek; Robert A Smith; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-03-05       Impact factor: 508.702

Review 4.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.

Authors:  F Petrelli; E Pezzica; M Cabiddu; A Coinu; K Borgonovo; M Ghilardi; V Lonati; D Corti; S Barni
Journal:  J Gastrointest Cancer       Date:  2015-09

5.  Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.

Authors:  Heather Dawson; Francesca Galuppini; Peter Träger; Martin D Berger; Peter Studer; Lukas Brügger; Inti Zlobec; Daniel Inderbitzin; Alessandro Lugli
Journal:  Hum Pathol       Date:  2018-11-11       Impact factor: 3.466

6.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

7.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

8.  Tumor budding as an index to identify high-risk patients with stage II colon cancer.

Authors:  Takatoshi Nakamura; Hiroyuki Mitomi; Hideki Kanazawa; Yasuo Ohkura; Masahiko Watanabe
Journal:  Dis Colon Rectum       Date:  2008-02-20       Impact factor: 4.585

9.  Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.

Authors:  Hideki Ueno; Kazuo Hase; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinji Yoshii; Shin-ei Kudo; Masafumi Tanaka; Yoshito Akagi; Takeshi Suto; Shinji Nagata; Keiji Matsuda; Koji Komori; Kazuhiko Yoshimatsu; Yasuhiko Tomita; Shozo Yokoyama; Eiji Shinto; Takahiro Nakamura; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-09-25       Impact factor: 7.527

Review 10.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.